ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

GLUE Monte Rosa Therapeutics Inc

5.65
0.05 (0.89%)
After Hours
Last Updated: 06:02:01
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Monte Rosa Therapeutics Inc GLUE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.05 0.89% 5.65 06:02:01
Open Price Low Price High Price Close Price Previous Close
5.82 5.645 5.85 5.65 5.60
more quote information »

Recent News

Date Time Source Heading
03/5/202406:01GLOBEMonte Rosa Therapeutics Announces the Departure of Owen..
14/3/202422:00GLOBEMonte Rosa Therapeutics Announces Fourth Quarter and Full..
11/3/202422:00GLOBEMonte Rosa Therapeutics Announces Initiation of IND Enabling..
31/1/202423:00GLOBEMonte Rosa Therapeutics to Participate in Upcoming Investor..
08/1/202423:47EDGAR2Form 8-K - Current report
08/1/202423:15GLOBEMonte Rosa Therapeutics Provides Corporate Update and Key..
05/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:00GLOBEMonte Rosa Therapeutics to Present at the 42nd Annual J.P...
21/11/202323:00GLOBEMonte Rosa Therapeutics to Present at Piper Sandler..
09/11/202323:27EDGAR2Form 8-K - Current report
09/11/202323:00GLOBEMonte Rosa Therapeutics Announces Third Quarter 2023..
08/11/202302:00GLOBEMonte Rosa Therapeutics Presents Preclinical Data at ACR..
27/10/202322:00GLOBEMonte Rosa Therapeutics to Participate in Upcoming Investor..
27/10/202308:01EDGAR2Form 8-K - Current report
27/10/202307:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/10/202307:30GLOBEMonte Rosa Therapeutics Announces $25 Million Registered..
17/10/202322:55EDGAR2Form 8-K - Current report
17/10/202322:00GLOBEMonte Rosa Therapeutics Announces Interim PK/PD and Clinical..
19/8/202306:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/8/202307:16EDGAR2Form 144 - Report of proposed sale of securities
10/8/202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202321:19EDGAR2Form 8-K - Current report
10/8/202321:15GLOBEMonte Rosa Therapeutics Announces Second Quarter 2023..
26/7/202321:53EDGAR2Form 8-K - Current report
26/7/202321:30GLOBEMonte Rosa Therapeutics Appoints Dr. Anthony M. Manning to..
31/5/202306:30GLOBEMonte Rosa Therapeutics to Present at Upcoming Investor and..
23/5/202321:30GLOBEMonte Rosa Therapeutics Advances Second Development..
11/5/202321:30GLOBEMonte Rosa Therapeutics Announces First Quarter 2023..

Your Recent History

Delayed Upgrade Clock